The closing price of Organon & Co. (NYSE: OGN) was $18.30 for the day, up 0.83% from the previous closing price of $18.15. In other words, the price has increased by $+0.15 from its previous closing price. On the day, 1612129 shares were traded.
Ratios:
Our analysis of OGN’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.75 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.54. For the most recent quarter (mrq), Quick Ratio is recorded 1.09 and its Current Ratio is at 1.54.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on November 03, 2023, Downgraded its rating to Neutral and sets its target price to $16 from $33 previously.
On September 21, 2023, Barclays started tracking the stock assigning a Overweight rating and target price of $28.
On March 16, 2023, Raymond James started tracking the stock assigning a Outperform rating and target price of $33.Raymond James initiated its Outperform rating on March 16, 2023, with a $33 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 22 ’24 when Weaver Kirke bought 2,720 shares for $18.36 per share. The transaction valued at 49,939 led to the insider holds 15,181 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OGN now has a Market Capitalization of 4.68B and an Enterprise Value of 12.75B. As of this moment, Organon’s Price-to-Earnings (P/E) ratio for their current fiscal year is 4.59, and their Forward P/E ratio for the next fiscal year is 4.06. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.75. Its current Enterprise Value per Revenue stands at 2.03 whereas that against EBITDA is 8.88.
Stock Price History:
Over the past 52 weeks, OGN has reached a high of $24.79, while it has fallen to a 52-week low of $10.84. The 50-Day Moving Average of the stock is 17.32, while the 200-Day Moving Average is calculated to be 17.48.
Shares Statistics:
OGN traded an average of 3.07M shares per day over the past three months and 2.34M shares per day over the past ten days. A total of 255.63M shares are outstanding, with a floating share count of 255.25M. Insiders hold about 0.15% of the company’s shares, while institutions hold 79.17% stake in the company. Shares short for OGN as of Feb 29, 2024 were 9.71M with a Short Ratio of 3.16, compared to 12.33M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 3.80% and a Short% of Float of 4.34%.
Dividends & Splits
With its trailing 12-month dividend rate of 1.12, OGN has a forward annual dividend rate of 1.12. Against a Trailing Annual Dividend Yield of 6.17%, it implies a Forward Annual Dividend Yield of 6.12%.
Earnings Estimates
The firm’s stock currently is rated by 6 analysts. On average, analysts expect EPS of $1.06 for the current quarter, with a high estimate of $1.19 and a low estimate of $0.9, while EPS last year was $1.08. The consensus estimate for the next quarter is $1.12, with high estimates of $1.22 and low estimates of $1.02.
Analysts are recommending an EPS of between $4.51 and $4.13 for the fiscal current year, implying an average EPS of $4.32. EPS for the following year is $4.51, with 8 analysts recommending between $4.73 and $4.35.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 5 analysts. It ranges from a high estimate of $1.61B to a low estimate of $1.53B. As of the current estimate, Organon & Co.’s year-ago sales were $1.55B, an estimated increase of 1.80% from the year-ago figure. For the next quarter, 5 analysts are estimating revenue of $1.64B, an increase of 4.40% over than the figure of $1.80% in the same quarter last year. There is a high estimate of $1.7B for the next quarter, whereas the lowest estimate is $1.61B.
A total of 8 analysts have provided revenue estimates for OGN’s current fiscal year. The highest revenue estimate was $6.47B, while the lowest revenue estimate was $6.32B, resulting in an average revenue estimate of $6.4B. In the same quarter a year ago, actual revenue was $6.26B, up 2.20% from the average estimate. Based on 8 analysts’ estimates, the company’s revenue will be $6.52B in the next fiscal year. The high estimate is $6.8B and the low estimate is $6.34B. The average revenue growth estimate for next year is up 1.80% from the average revenue estimate for this year.
